Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Jason J. Schwartz"'
Publikováno v:
Drugs in R&D, Vol 19, Iss 2, Pp 201-212 (2019)
Abstract Background and Objective Given that a high intrapatient variability (IPV) of tacrolimus whole blood concentration increases the risk for a poor kidney transplant outcome, some experts advocate routine IPV monitoring for detection of high-ris
Externí odkaz:
https://doaj.org/article/fb3baa81bce74d509af0e9d63bfdc90d
Autor:
Sandra M. Cockfield, Patricia M. Campbell, Marcelo Cantarovich, Azim Gangji, Ahmed Shoker, Anthony M. Jevnikar, Felix-Mauricio Monroy-Cuadros, Peter W. Nickerson, Michel R. Pâquet, G. V. Ramesh Prasad, Lynne Senécal, Jason J. Schwartz, Jean-Luc Wolff, David Rush
Publikováno v:
Transplantation. 106:S199-S199
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92cb16f8d79c5800ea5db7f079b99858
https://doi.org/10.1097/01.tp.0000886376.35615.a8
https://doi.org/10.1097/01.tp.0000886376.35615.a8
Autor:
Tammy Keough-Ryan, Patricia Campbell, Michel Pâquet, Isabelle Houde, Peter Nickerson, Jean‐Luc Wolff, Ahmed Shoker, Lynne Senécal, Jason J. Schwartz, Felix‐Mauricio Monroy‐Cuadros, Sam Wilson, Marcelo Cantarovich, G. V. Ramesh Prasad, John Howell, A. M. Jevnikar, Azim S. Gangji, Sandra M. Cockfield, David N. Rush
Publikováno v:
American Journal of Transplantation
Targeting the renin‐angiotensin system and optimizing tacrolimus exposure are both postulated to improve outcomes in renal transplant recipients (RTRs) by preventing interstitial fibrosis/tubular atrophy (IF/TA). In this multicenter, prospective, o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62eb1a77ec786cd12c062a2a4dc8472b
https://doi.org/10.1111/ajt.15225
https://doi.org/10.1111/ajt.15225
Publikováno v:
Drugs in R&D
Drugs in R&D, Vol 19, Iss 2, Pp 201-212 (2019)
Drugs in R&D, Vol 19, Iss 2, Pp 201-212 (2019)
Background and Objective Given that a high intrapatient variability (IPV) of tacrolimus whole blood concentration increases the risk for a poor kidney transplant outcome, some experts advocate routine IPV monitoring for detection of high-risk patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cde2c7ec858c616d7ea9ba2bd33bf29
https://doi.org/10.1007/s40268-019-0271-2
https://doi.org/10.1007/s40268-019-0271-2
Autor:
Billy Franks, David P. Facklam, William Irish, Edward Lee, James Spalding, Gary D. Thal, Ashley P. Butler, Jason J. Schwartz, Maria Vassilakis
Publikováno v:
Advances in Therapy
Introduction It was hypothesized that patients experiencing at least one tacrolimus formulation switch may require more frequent therapeutic drug monitoring, subsequent dose adjustments, and a potential for untoward clinical outcomes than patients wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a66406aa57cb0c36d219c4d8f18efae
https://doi.org/10.1007/s12325-019-00950-5
https://doi.org/10.1007/s12325-019-00950-5
Autor:
Billy Franks, Brandon T. Suehs, Gary D. Thal, James Spalding, Jason J. Schwartz, Suvapun Bunniran, Edward Lee, Pravin Kamble
Publikováno v:
Journal of Medical Economics. 21:1067-1074
Switching drug manufacturers in transplant patients may require an increased intensity of therapeutic monitoring, leading to additional healthcare visits, associated laboratory tests, and perhaps hospitalizations. As real-world studies examining the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ccd92d8a272ff48317ee7509d80f4e7
https://doi.org/10.1080/13696998.2018.1503596
https://doi.org/10.1080/13696998.2018.1503596
Autor:
Milan E Folkers, Don A Delker, Christopher I Maxwell, Cassie A Nelson, Jason J Schwartz, David A Nix, Curt H Hagedorn
Publikováno v:
PLoS ONE, Vol 6, Iss 2, p e14697 (2011)
Microarray studies of chronic hepatitis C infection have provided valuable information regarding the host response to viral infection. However, recent studies of the human transcriptome indicate pervasive transcription in previously unannotated regio
Externí odkaz:
https://doaj.org/article/a1d7e028ed974147955514ca87ac8da5
Publikováno v:
Advances in Therapy
Introduction We qualitatively examined the symptoms and impact of recurrent primary focal segmental glomerulosclerosis (rpFSGS) in kidney transplant recipients, compared with two related FSGS populations, to characterize the experience of patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8901dbd1d7ed6db7d38902ce2001e707
https://pubmed.ncbi.nlm.nih.gov/31612357
https://pubmed.ncbi.nlm.nih.gov/31612357
Autor:
Anton I. Skaro, Jason J. Schwartz, Samantha Montag, Raymond Kang, Kofi Atiemo, Bing Ho, Edward Lee, Lihui Zhao, Amna Daud, Daniela P. Ladner, Hardik Bhagat
Publikováno v:
Advances in Therapy
Introduction Real-world data with extended-release tacrolimus (ER-T) are lacking in the USA. This study examined clinical outcomes and healthcare resource utilization in kidney transplant patients receiving ER-T in clinical practice. Methods This was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51254b37c17744e44b225c977ea72b64
https://pubmed.ncbi.nlm.nih.gov/30941724
https://pubmed.ncbi.nlm.nih.gov/30941724
Publikováno v:
Transplantation proceedings. 50(10)
Background Black kidney transplant patients experience inferior outcomes compared with other ethnicities. Because scrutiny is required when immunosuppressant drugs are used in such at-risk populations, we report the first large-scale clinical efficac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::014b21bfe5998600ec3ee878abf43034
https://pubmed.ncbi.nlm.nih.gov/30577198
https://pubmed.ncbi.nlm.nih.gov/30577198